Hypnosis for smoking cessation: a randomized trial. 2008

Timothy P Carmody, and Carol Duncan, and Joel A Simon, and Sharon Solkowitz, and Joy Huggins, and Sharon Lee, and Kevin Delucchi
San Francisco Veterans Affairs Medical Center, University of California, San Francisco, CA, USA. Timothy.Carmody@ucsf.edu

The purpose of this study was to determine whether hypnosis would be more effective in helping smokers quit than standard behavioral counseling when both interventions are combined with nicotine patches (NP). A total of 286 current smokers were enrolled in a randomized controlled smoking cessation trial at the San Francisco Veterans Affairs Medical Center. Participants in both treatment conditions were seen for two 60-min sessions, and received three follow-up phone calls and 2 months of NP. At 6 months, 29% of the hypnosis group reported 7-day point-prevalence abstinence compared with 23% of the behavioral counseling group (relative risk [RR] = 1.27; 95% confidence interval, CI 0.84-1.92). Based on biochemical or proxy confirmation, 26% of the participants in the hypnosis group were abstinent at 6 months compared with 18% of the behavioral group (RR = 1.44; 95% CI 0.91-2.30). At 12 months, the self-reported 7-day point-prevalence quit rate was 24% for the hypnosis group and 16% for the behavioral group (RR = 1.47; 95% CI 0.90-2.40). Based on biochemical or proxy confirmation, 20% of the participants in the hypnosis group were abstinent at 12 months compared with 14% of the behavioral group (RR = 1.40; 95% CI 0.81-2.42). Among participants with a history of depression, hypnosis yielded significantly higher validated point-prevalence quit rates at 6 and 12 months than standard treatment. It was concluded that hypnosis combined with NP compares favorably with standard behavioral counseling in generating long-term quit rates.

UI MeSH Term Description Entries
D006990 Hypnosis A state of increased receptivity to suggestion and direction, initially induced by the influence of another person or oneself. Autohypnosis,Clinical Hypnosis,Hypnoanalysis,Mesmerism,Self-Hypnosis,Hypnotherapy,Hypnotism,Hypnosis, Clinical,Hypnotherapies,Self Hypnosis
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009538 Nicotine Nicotine is highly toxic alkaloid. It is the prototypical agonist at nicotinic cholinergic receptors where it dramatically stimulates neurons and ultimately blocks synaptic transmission. Nicotine is also important medically because of its presence in tobacco smoke. Nicotine Bitartrate,Nicotine Tartrate
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005260 Female Females
D005731 Ganglionic Stimulants Agents that mimic neural transmission by stimulation of the nicotinic receptors on postganglionic autonomic neurons. Drugs that indirectly augment ganglionic transmission by increasing the release or slowing the breakdown of acetylcholine or by non-nicotinic effects on postganglionic neurons are not included here nor are the nonspecific cholinergic agonists. Stimulants, Ganglionic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000279 Administration, Cutaneous The application of suitable drug dosage forms to the skin for either local or systemic effects. Cutaneous Drug Administration,Dermal Drug Administration,Drug Administration, Dermal,Percutaneous Administration,Skin Drug Administration,Transcutaneous Administration,Transdermal Administration,Administration, Dermal,Administration, Transcutaneous,Administration, Transdermal,Cutaneous Administration,Cutaneous Administration, Drug,Dermal Administration,Drug Administration, Cutaneous,Skin Administration, Drug,Administration, Cutaneous Drug,Administration, Dermal Drug,Administration, Percutaneous,Administrations, Cutaneous,Administrations, Cutaneous Drug,Administrations, Dermal,Administrations, Dermal Drug,Administrations, Percutaneous,Administrations, Transcutaneous,Administrations, Transdermal,Cutaneous Administrations,Cutaneous Administrations, Drug,Cutaneous Drug Administrations,Dermal Administrations,Dermal Drug Administrations,Drug Administrations, Cutaneous,Drug Administrations, Dermal,Drug Skin Administrations,Percutaneous Administrations,Skin Administrations, Drug,Skin Drug Administrations,Transcutaneous Administrations,Transdermal Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Timothy P Carmody, and Carol Duncan, and Joel A Simon, and Sharon Solkowitz, and Joy Huggins, and Sharon Lee, and Kevin Delucchi
July 1999, Ugeskrift for laeger,
Timothy P Carmody, and Carol Duncan, and Joel A Simon, and Sharon Solkowitz, and Joy Huggins, and Sharon Lee, and Kevin Delucchi
January 1984, Addictive behaviors,
Timothy P Carmody, and Carol Duncan, and Joel A Simon, and Sharon Solkowitz, and Joy Huggins, and Sharon Lee, and Kevin Delucchi
August 1999, Addiction (Abingdon, England),
Timothy P Carmody, and Carol Duncan, and Joel A Simon, and Sharon Solkowitz, and Joy Huggins, and Sharon Lee, and Kevin Delucchi
October 1998, Archives of internal medicine,
Timothy P Carmody, and Carol Duncan, and Joel A Simon, and Sharon Solkowitz, and Joy Huggins, and Sharon Lee, and Kevin Delucchi
July 2023, JAMA,
Timothy P Carmody, and Carol Duncan, and Joel A Simon, and Sharon Solkowitz, and Joy Huggins, and Sharon Lee, and Kevin Delucchi
January 1986, International journal of psychosomatics : official publication of the International Psychosomatics Institute,
Timothy P Carmody, and Carol Duncan, and Joel A Simon, and Sharon Solkowitz, and Joy Huggins, and Sharon Lee, and Kevin Delucchi
June 1997, Archives of internal medicine,
Timothy P Carmody, and Carol Duncan, and Joel A Simon, and Sharon Solkowitz, and Joy Huggins, and Sharon Lee, and Kevin Delucchi
January 1989, American journal of health promotion : AJHP,
Timothy P Carmody, and Carol Duncan, and Joel A Simon, and Sharon Solkowitz, and Joy Huggins, and Sharon Lee, and Kevin Delucchi
January 1986, The Journal of family practice,
Timothy P Carmody, and Carol Duncan, and Joel A Simon, and Sharon Solkowitz, and Joy Huggins, and Sharon Lee, and Kevin Delucchi
July 2014, Drug and alcohol dependence,
Copied contents to your clipboard!